Phenotypic and genotypic mupirocin resistance among staphylococci causing prosthetic joint infection

Journal of Clinical Microbiology

Volumn 43, Issue 8, 2005, Pages 4266-4268

  Rotger, Margalida ^a   Trampuz, Andrej ^a   Piper, Kerryl E ^a   Steckelberg, James M ^a   Patel, Robin ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; COAGULASE NEGATIVE STAPHYLOCOCCUS; GENETIC ANALYSIS; GENOTYPE; HUMAN; JOINT PROSTHESIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MUPA GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTHESIS INFECTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; JOINT PROSTHESIS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; MUPIROCIN; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

STAPHYLOCOCCI; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 23744486085     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.8.4266-4268.2005     Document Type: Article

References (28)

1. Chang, F. Y., N. Singh, T. Gayowski, S. D. Drenning, M. M. Wagener, and I. R. Marino. 1998. Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 65:1169-1172.
2. Chaves, F., J. Garcia-Martinez, S. de Miguel, and J. R. Otero. 2004. Molecular characterization of resistance to mupirocin in methicillin-susceptible and -resistant isolates of Staphylococcus aureus from nasal samples. J. Clin. Microbiol. 42:822-824.
3. Cookson, B. D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 41:11-18.
4. Decousser, J. W., P. Pina, J. C. Ghnassia, J. P. Bedos, and P. Y. Allouch. 2003. First report of clinical and microbiological failure in the eradication of glycopeptide-intermediate methicillin-resistant Staphylococcus aureus carriage by mupirocin. Eur. J. Clin. Microbiol. Infect. Dis. 22:318-319.
5. Fujimura, S., A. Watanabe, and D. Beighton. 2001. Characterization of the mupA gene in strains of methicillin-resistant Staphylococcus aureus with a low level of resistance to mupirocin. Antimicrob. Agents Chemother. 45:641-642.
6. Gilbart, J., C. R. Perry, and B. Slocombe. 1993. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob. Agents Chemother. 37:32-38.
7. Harbarth, S., S. Dharan, N. Liassine, P. Herrault, R. Auckenthaler, and D. Pittet. 1999. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 43:1412-1416.
8. Hodgson, J. E., S. P. Curnock, K. G. Dyke, R. Morris, D. R. Sylvester, and M. S. Gross. 1994, Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrob. Agents Chemother. 38:1205-1208.
9. Kalmeijer, M. D., E. van Nieuwland-Bollen, D. Bogaers-Hofman, and G. A. de Baere. 2000. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect. Control Hosp. Epidemiol. 21:319-323.
10. Kluytmans, J., A. van Belkum, and H. Verbrugh. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10:505-520.
11. Kolbert, C., P. Rys, M. Hopkins, D. Lynch, J. Germer, C. O'Sullivan, A. Trampuz, and R. Patel. 2004. 16S ribosomal DNA sequence analysis for identification of bacteria in a clinical microbiology laboratory. In D. Persing, F. Tenover, J. Versalovic, Y. Tang, E. Unger, D. Relman, and T. White (ed.), Molecular microbiology: diagnostic principles and practice. ASM Press, Washington, D.C.
12. Kresken, M., D. Hafner, F. J. Schmitz, and T. A. Wichelhaus. 2004. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. Int. J. Antimicrob. Agents 23:577-581.
13. Leski, T. A., M. Gniadkowski, A. Skoczynska, E. Stefaniuk, K. Trzcinski, and W. Hryniewicz. 1999. Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains. J. Clin. Microbiol. 37:2781-2788.
14. Mody, L., C. A. Kauffman, S. A. McNeil, A. T. Galecki, and S. F. Bradley. 2003. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37:1467-1474.
15. NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. NCCLS, Wayne, Pa.
16. Petinaki, E., I. Spiliopoulou, F. Kontos, M. Maniati, Z. Bersos, N. Stakias, H. Malamou-Lada, C. Koutsia-Carouzou, and A. N. Maniatis. 2004. Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals. J. Antimicrob. Chemother. 53:105-108.
17. Rahman, M., S. Connolly, W. C. Noble, B. Cookson, and I. Phillips. 1990. Diversity of staphylococci exhibiting high-level resistance to mupirocin. J. Med. Microbiol. 33:97-100.
18. Ramsey, M. A., S. F. Bradley, C. A. Kauffman, and T. M. Morton. 1996. Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob. Agents Chemother. 40:2820-2823.
19. Ramsey, M. A., S. F. Bradley, C. A. Kauffman, T. M. Morton, J. E. Patterson, and D. R. Reagan. 1998. Characterization of mupirocin-resistant Staphylococcus aureus from different geographic areas. Antimicrob. Agents Chemother. 42:1305. (Letter.)
20. Schmitz, F. J., E. Lindenlauf, B. Hofmann, A. C. Fluit, J. Verhoef, H. P. Heinz, and M. E. Jones. 1998. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J. Antimicrob Chemother. 42:489-495.
21. Tomic, V., P. Svetina Sorli, D. Trinkaus, J. Sorli, A. F. Widmer, and A. Trumpuz. 2004. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch. Intern. Med. 164:2038-2043.
22. Trampuz, A., D. R. Osmon, A. D. Hanssen, J. M. Steckelberg, and R. Patel. 2003. Molecular and antibiofilm approaches to prosthetic joint infection. Clin. Orthop. Relat. Res. 2003:69-88.
23. Udo, E. E., L. E. Jacob, and E. M. Mokadas. 1997. Conjugative transfer of high-level mupirocin resistance from Staphylococcus haemolyticus to other staphylococci. Antimicrob. Agents Chemother. 41:693-695.
24. von Eiff, C., K. Becker, K. Machka, H. Stammer, G. Peters, et al. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
25. Walker, E. S., J. E. Vasquez, R. Dula, H. Bullock, and F. A. Sarubbi. 2003. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective? Infect. Control Hosp. Epidemiol. 24:342-346.
26. Wilcox, M. H., J. Hall, H. Pike, P. A. Templeton, W. N. Fawley, P. Parnell, and P. Verity. 2003. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J. Hosp. Infect. 54:196-201.
27. Yun, H. J., S. W. Lee, G. M. Yoon, S. Y. Kim, S. Choi, Y. S. Lee, E. C. Choi, and S. Kim. 2003. Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J. Antimicrob. Chemother. 51:619-623.
28. Zimmerli, W., A. Trampuz, and P. E. Ochsner. 2004. Prosthetic-joint infections. N. Engl. J. Med. 351:1645-1654.